NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Type 2 Diabetes Mellitus
Date of first enrollment	12/07/2010
Target sample size	275
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : TS-071 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral control material(s) Generic name etc : Placebo INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	HbA1c
Secondary Outcome	Blood-sugar level, etc.

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 74age old
Gender	Both
Include criteria	- Type 2 diabetes mellitus - HbA1c 6.5% to 10.0% etc.
Exclude criteria	- Insulin-dependent (Require insulin regularly) - Non-type 2 diabetes mellitus - Having critical heart disease, other ciruculatory disease, cerebrovascular disorder, pancreatic disease and hematologic disease etc.